home / stock / hbi / hbi articles
HanesBrands Inc (NYSE:HBI) shares are trading lower after the company reported fourth-quarter FY23 results. Sales declined 12% Y/Y to $1....
U.S. stocks could build on their gains on Thursday, with the index futures holding modestly higher. Traders seemed to be cautiously optimistic abou...
DXC Technology to empower HanesBrands' global workforce with Modern Workplace solutions ASHBURN, Va., Nov. 21, 2023 /PRNewswire/ - DXC Technolo...
The stock markets is in a lackluster session on Thursday, with traders eagerly awaiting more clues on monetary policy from Fed Chair Jerome Powell,...
HanesBrands Inc (NYSE: HBI) reported a third-quarter FY23 sales decline of 9.6% year-on-year to $1.51 billion, missing the analyst consen...
The stock market’s momentum appears to be waning, and futures suggest a mixed opening for Thursday. Earnings reports have generally been posi...
HanesBrands (NYSE: HBI) explores strategic options for its global Champion business, including a potential sale or other strate...
G-III Apparel Group Ltd (NASDAQ: GIII) reported second-quarter FY24 sales growth of 9% year-on-year to $659.76 million, beating the ...
News, Short Squeeze, Breakout and More Instantly...
A partnership between HanesBrands and Foundation Educating a Salvadoran (FESA) has benefited more than 2,500 students through two soccer academies near its facilities in San Juan Opico and Santiago Nonualco, El Salvador. NORTHAMPTON, MA / ACCESSWIRE / June 28, 2024 / HanesBrands Originally ...
HOLLISTON, Mass., June 06, 2024 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) today announced that Jim Green, Chairman and Chief Executive Officer, and Jennifer Cote, Chief Financial Officer, will be presenting to investors at the 14 th Annual East Coast IDEAS Conference at the ...
2024-06-05 19:15:02 ET UBS analyst issues NEUTRAL recommendation for HBI on June 5, 2024 05:20PM ET. The previous analyst recommendation was Neutral. HBI was trading at $5.3 at issue of the analyst recommendation. The overall analyst consensus : HOLD. Current analyst...